Authors
Oshrat E Tayer-Shifman, Itamar Ben Shitrit, Itay Zahavi, Yael Pri-Paz Basson, Shaye Kivity, Lior Nesher, Iftach Sagy
Published in
Rheumatology (Oxford, England). Nov 06, 2026. Epub Nov 06, 2026.
Abstract
To evaluate longitudinal patterns of vaccination uptake and respiratory infection outcomes among patients with systemic lupus erythematosus (SLE) compared with controls and identify factors associated with vaccination uptake.
Population-based cohort study using a healthcare organization database. Adult patients with SLE (diagnosed 2010-2023) were identified through a validated registry and matched 1:100 to controls by birth year, sex, and socioeconomic status. Vaccination uptake for influenza, pneumococcal, and COVID-19 vaccines, respiratory infections, hospitalizations, intensive care unit (ICU) admissions, and mortality were evaluated. Temporal trends and factors associated with vaccination uptake were assessed using multivariable models.
The study included 3,692 patients with SLE and 382,753 matched controls (median follow-ups 12.8 and 13.4 years, respectively). Vaccination uptake was higher among patients with SLE than controls (influenza: 77.6% vs. 56.4%; pneumococcal: 55.6% vs. 32.1%; COVID-19: 74.2% vs. 72.0%; all p < 0.01). Patients with SLE experienced higher rates of respiratory hospitalization (34.8% vs. 11.5%), pneumonia hospitalization (23.9% vs. 5.9%), ICU admission (12.8% vs. 2.7%), and all-cause mortality (21.0% vs. 8.5%) (all p < 0.001). Longitudinally, vaccination uptake and respiratory hospitalizations remained consistently higher among patients with SLE. Pneumonia hospitalization rates increased over time in controls but remained stable in SLE (interaction p = 0.020). Older age, more comorbidities, higher socioeconomic status, and exposure to glucocorticoids were independently associated with influenza and pneumococcal vaccination uptake rates in SLE.
Patients with SLE demonstrated substantially higher vaccine exposure than controls but experienced elevated respiratory infection rates and severe outcomes. These findings support efforts to optimize infection prevention strategies in SLE.
PMID:
42992943
Bibliographic data and abstract were imported from PubMed on 06 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 12
- Comments 0